-+ 0.00%
-+ 0.00%
-+ 0.00%

Canaccord Genuity Initiates Coverage On Caris Life Sciences with Hold Rating, Announces Price Target of $28

Benzinga·12/02/2025 12:31:20
Listen to the news
Canaccord Genuity analyst Kyle Mikson initiates coverage on Caris Life Sciences (NASDAQ:CAI) with a Hold rating and announces Price Target of $28.